Finding That Needle in the Haystack: Computable Phenotypes
- 15 November 2019
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 30 (12) , 2279-2280
Abstract
Recruitment of patients for clinical trials is an area ready for innovation. At a time when there is measurable interest and support from industry sponsoring clinical trials in the glomerular disease space, connecting the right patients to the right trials as efficiently as possible is of great import. Harnessing data from electronic health records (EHRs) to streamline and personalize clinical trial recruitment using computable phenotypes has the potential to decrease the time and money associated with clinical trial setup. Indeed, global spending on clinical trial technology and services is expected to reach $69 billion per year by 2025.3 EHR-powered analytic tools are already commercialized for the purposes of protocol feasibility, cohort analysis, and study site identification.Keywords
This publication has 5 references indexed in Scilit:
- Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical ResearchJournal of the American Society of Nephrology, 2019
- Development and Validation of a Pragmatic Electronic Phenotype for CKDClinical Journal of the American Society of Nephrology, 2019
- Clinical trial costs go under the microscopeNature Medicine, 2019
- PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportabilityJournal of the American Medical Informatics Association, 2016
- A Needle in A Meadow : A Missing reference in the More-Frith ControversyMoreana, 1976